MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 165 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $14,155,000 | +74.8% | 425,465 | +42.9% | 0.03% | +50.0% |
| Q1 2020 | $8,099,000 | -1.1% | 297,741 | -28.2% | 0.02% | +29.4% |
| Q4 2019 | $8,186,000 | +1477.3% | 414,900 | +935.7% | 0.02% | +1600.0% |
| Q3 2019 | $519,000 | +4.0% | 40,059 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $499,000 | -11.7% | 40,059 | +3.0% | 0.00% | 0.0% |
| Q1 2019 | $565,000 | +57.4% | 38,903 | +19.5% | 0.00% | 0.0% |
| Q4 2018 | $359,000 | -56.6% | 32,544 | +3.4% | 0.00% | -50.0% |
| Q3 2018 | $828,000 | +28.8% | 31,465 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $643,000 | +7.5% | 31,465 | -4.5% | 0.00% | 0.0% |
| Q1 2018 | $598,000 | -24.0% | 32,933 | -41.7% | 0.00% | -50.0% |
| Q4 2017 | $787,000 | -39.1% | 56,445 | -19.2% | 0.00% | -33.3% |
| Q3 2017 | $1,292,000 | -17.1% | 69,824 | -24.3% | 0.00% | 0.0% |
| Q2 2017 | $1,558,000 | -5.1% | 92,209 | -25.0% | 0.00% | -25.0% |
| Q1 2017 | $1,642,000 | +304.4% | 123,006 | +356.4% | 0.00% | +300.0% |
| Q4 2016 | $406,000 | +28.9% | 26,950 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $315,000 | +8.2% | 26,950 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $291,000 | +16.9% | 26,950 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $249,000 | -37.8% | 26,950 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $400,000 | -90.3% | 26,950 | -89.3% | 0.00% | -90.0% |
| Q3 2015 | $4,115,000 | -56.2% | 250,745 | -39.1% | 0.01% | -54.5% |
| Q2 2015 | $9,398,000 | +15.3% | 412,051 | -23.1% | 0.02% | +22.2% |
| Q1 2015 | $8,149,000 | +90.8% | 536,080 | +51.1% | 0.02% | +100.0% |
| Q4 2014 | $4,272,000 | +6.2% | 354,880 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $4,024,000 | -6.2% | 354,880 | -0.1% | 0.01% | -10.0% |
| Q2 2014 | $4,292,000 | +1.6% | 355,281 | -2.0% | 0.01% | 0.0% |
| Q1 2014 | $4,223,000 | -37.2% | 362,581 | -4.7% | 0.01% | -37.5% |
| Q4 2013 | $6,728,000 | +22.1% | 380,561 | -0.7% | 0.02% | +14.3% |
| Q3 2013 | $5,512,000 | -12.6% | 383,061 | -8.5% | 0.01% | -17.6% |
| Q2 2013 | $6,307,000 | – | 418,810 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 159,197 | $5,296,000 | 4.06% |
| Ghost Tree Capital, LLC | 385,000 | $12,809,000 | 3.38% |
| Copernicus Capital Management, LLC | 88,000 | $2,928,000 | 3.21% |
| Palo Alto Investors LP | 1,479,524 | $49,224,000 | 2.96% |
| Redmile Group, LLC | 4,705,308 | $156,546,000 | 2.89% |
| Avidity Partners Management LP | 1,150,000 | $38,261,000 | 2.45% |
| RA Capital Management | 2,531,445 | $84,221,000 | 1.64% |
| MAVERICK CAPITAL LTD | 2,314,756 | $77,012,000 | 1.62% |
| Integral Health Asset Management, LLC | 150,000 | $4,991,000 | 1.50% |
| PFM Health Sciences, LP | 579,994 | $19,296,000 | 1.00% |